The Anglo-Swedish pharmaceutical giant AstraZeneca faces mounting pressure from shareholders regarding ongoing investigations in China, one of its key markets. The concerns emerged after the detention ...
A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...
Wang Fujiyama oversees Associated Press coverage across China, Hong Kong, Taiwan and Mongolia. Previously she was a video journalist in Beijing and Tokyo.
Investor's Business Daily on MSN5d
AstraZeneca Could Pay $4.5 Million In China Scandal. Here's Why Shares Jumped.AstraZeneca stock rose early Thursday after the drugmaker beat fourth-quarter earnings views and delivered upbeat guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback